Investment Review Report
웰팜
Business Reg. No. 1308616791 · CEO 최규황
I.Investment Overview
| Target | 웰팜 (1308616791) |
| Investment | — |
| Post-deal stake | — |
| Valuation | Pre — / Post — |
II.Investment Highlights
No investment highlights written yet.
III.Investment Risks
No risks written yet.
IV.Company Profile
| 회사명 | 웰팜 |
| 영문명 | wellpharm |
| 대표자 | 최규황 |
| 사업자등록번호 | 1308616791 |
| 법인등록번호 | 1211110137993 |
| 설립일 | 2005.10.19 |
| 종업원수 | 24명 |
V.Workforce
24
Current headcount · 2026.06 as of
VI.Financial Summary
Per DART disclosure · in 억/만원 (KRW)
Financial trend (100M KRW)
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| 자산총계 | 157.6억원 | 163.8억원 | 164.8억원 | 161.6억원 | 161.8억원 |
| 부채총계 | 127.1억원 | 137억원 | 123.5억원 | 120.6억원 | 123.1억원 |
| 자본총계 | 30.5억원 | 26.8억원 | 41.3억원 | 41억원 | 38.7억원 |
| 매출액 | 280.2억원 | 275.2억원 | 249.1억원 | 216.1억원 | 209.6억원 |
| 영업이익 | 9.1억원 | 4.8억원 | 5.3억원 | 3.2억원 | -4.8억원 |
| 순이익 | 3.7억원 | — | 3,272만원 | 2.2억원 | 5.4억원 |
VII.Financial Ratios
FY2025 basis
3.25%
영업이익률
1.33%
순이익률
2.36%
ROA
12.18%
ROE
416.69%
부채비율
19.35%
자기자본비율
VIII.Valuation & Exit Plan
| Exit valuation | — |
| Holding period | 5y |
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.
This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.